NASS presentations: Biological Products Show Promise, but More Evidence Is Needed

By

 
Biological Products Show Promise, but More Evidence Is Needed (NASS)
The use of biological products in spine treatments is increasing, but more reliable data about their use are needed, according to a series of presentations during the NASS Annual Meeting's final session, Biologics: A Critical Review of the Evidence.
During the November 5 symposium, six speakers discussed the need for more evidence about biologics, reviewed the level of evidence and examined biological materials, including demineralized bone matrix (DBM) and allograft stem cells.
The Need for Evidence
About 200,000 spi...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.